[Diphosphonates in the treatment of Paget's disease of bone]. 1987

T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain

UI MeSH Term Description Entries
D008297 Male Males
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077268 Pamidronate An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies. (3-Amino-1-hydroxypropylidene)-1,1-biphosphonate,1-Hydroxy-3-aminopropane-1,1-diphosphonic acid,AHPrBP,Amidronate,Amino-1-hydroxypropane-1,1-diphosphonate,Aminohydroxypropylidene Diphosphonate,Aminopropanehydroxydiphosphonate,Aredia,Pamidronate Calcium,Pamidronate Disodium,Pamidronate Monosodium,Pamidronic Acid,1 Hydroxy 3 aminopropane 1,1 diphosphonic acid,Amino 1 hydroxypropane 1,1 diphosphonate
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
April 1981, Schweizerische medizinische Wochenschrift,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
May 1974, Lancet (London, England),
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
October 1980, Arthritis and rheumatism,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
October 1979, Revue neurologique,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
February 1980, Lancet (London, England),
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
August 1973, Lancet (London, England),
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
January 1985, Bone,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
January 1985, Annals of the rheumatic diseases,
T Pepersack, and R Karmali, and C Gillet, and D François, and M Fuss, and S Orloff, and J Corvilain
December 1981, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!